Rekombinanter Myosin 9 Antikörper (Atto 488)

Produktnummer ABIN5564289

Der Human Monoklonal Anti-Myosin 9-Antikörper wurde für ICC validiert. Er ist geeignet, Myosin 9 in Proben von Human, Maus, Ratte und Drosophila melanogaster zu detektieren.

Kurzübersicht für Rekombinanter Myosin 9 Antikörper (Atto 488) (ABIN5564289)

Target: Myosin 9 (MYH9)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human, Maus, Ratte, Drosophila melanogaster

Wirt: Human

Klonalität: Monoklonal

Konjugat: Dieser Myosin 9 Antikörper ist konjugiert mit Atto 488

Applikation: Immunocytochemistry (ICC)

Klon: SF9

Produktdetails anti-Myosin 9 Antikörper (Atto 488)

Spezifität: Recognizes human, mouse, rat and drosophila myosin IIA (heavy chain).

Kreuzreaktivität: Fruchtfliege (Drosophila melanogaster), Human, Maus, Ratte (Rattus)

Reinheit: >95 % (SDS-PAGE)

Immunogen: Full length myosin IIA from rat liver.

Isotyp: IgG2

Anwendungsinformationen

Kommentare:

anti-Myosin IIA (non-muscle), monoclonal antibody (recombinant) (SF9) (ATTO 488) is composed of human variable regions (VH and VL) (lambda-chain) of immunoglobulin fused to the human lgG2 Fc domain and labeled with ATTO 488.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: In PBS containing 10 % glycerol and 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Short Term Storage: +4°C
Long Term Storage: +4°C
Keep conjugated formats at +4°C.

Details zu Myosin 9

Target: Myosin 9 (MYH9)

Andere Bezeichnung: Myosin IIA

Hintergrund: Anti-Myosin IIA (non-muscle), monoclonal antibody (recombinant) (SF9) is an antibody developed by antibody phage display technology using a human naive antibody gene library. These libraries consist of scFv (single chain fragment variable) composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) connected by a polypeptide linker. The antibody fragments are displayed on the surface of filamentous bacteriophage (M13). This scFv was selected by affinity selection on antigen in a process termed panning. Multiple rounds of panning are performed to enrich for antigen-specific scFv-phage. Monoclonal antibodies are subsequently identified by screening after each round of selection. The selected monoclonal scFv is cloned into an appropriate vector containing a Fc portion of interest and then produced in mammalian cells to generate an IgG like scFv-Fc fusion protein.

UniProt: P35579

Pathways: Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex